These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21139491)

  • 1. Acute hepatitis C in HIV-infected individuals: recommendations from the European AIDS Treatment Network (NEAT) consensus conference.
    European AIDS Treatment Network (NEAT) Acute Hepatitis C Infection Consensus Panel
    AIDS; 2011 Feb; 25(4):399-409. PubMed ID: 21139491
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnosis, evaluation, and treatment of HIV/HCV coinfection.
    Tedaldi E; Bean P
    Am Clin Lab; 2001; 20(9):26-32. PubMed ID: 11766416
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating hepatitis C in HIV-HCV coinfected patients.
    Tossing G
    Infection; 2002 Oct; 30(5):329-31. PubMed ID: 12420736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C in the patient with human immunodeficiency virus infection.
    Spengler U; Rockstroh JK
    J Hepatol; 1998 Dec; 29(6):1023-30. PubMed ID: 9875654
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy.
    Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT
    AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute hepatitis C in HIV-positive individuals.
    Low E; Vogel M; Rockstroh J; Nelson M
    AIDS Rev; 2008; 10(4):245-53. PubMed ID: 19092980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy of hepatitis C in HIV-coinfection.
    Rockstroh JK; Vogel M
    Eur J Med Res; 2004 Jun; 9(6):304-8. PubMed ID: 15257871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact and management of hepatitis B and hepatitis C virus co-infection in HIV patients.
    Kumar R; Singla V; Kacharya Sk
    Trop Gastroenterol; 2008; 29(3):136-47. PubMed ID: 19115605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic hepatitis C in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Halota W; Pawłowska M
    Przegl Epidemiol; 2002; 56 Suppl 5():41-5. PubMed ID: 15553071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of chronic viral hepatitis B/D and acute and chronic viral hepatitis C. The consensus of the German Society for Digestive and Metabolic Diseases].
    Hopf U; Niederau C; Kleber G; Fleig WE
    Z Gastroenterol; 1997 Nov; 35(11):971-86. PubMed ID: 9490556
    [No Abstract]   [Full Text] [Related]  

  • 12. Critical care of immunocompromised patients: human immunodeficiency virus.
    Rosen MJ; Narasimhan M
    Crit Care Med; 2006 Sep; 34(9 Suppl):S245-50. PubMed ID: 16917430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV/Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy.
    Chung RT; Kim AY; Polsky B
    Antivir Chem Chemother; 2001; 12 Suppl 1():73-91. PubMed ID: 11594692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastroduodenal opportunistic infections and dyspepsia in HIV-infected patients in the era of Highly Active Antiretroviral Therapy.
    Werneck-Silva AL; Prado IB
    J Gastroenterol Hepatol; 2009 Jan; 24(1):135-9. PubMed ID: 19054257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality due to liver failure and impact on survival of hepatitis virus infections in HIV-infected patients receiving potent antiretroviral therapy.
    Macías J; Melguizo I; Fernández-Rivera FJ; García-García A; Mira JA; Ramos AJ; Rivera JM; Pineda JA
    Eur J Clin Microbiol Infect Dis; 2002 Nov; 21(11):775-81. PubMed ID: 12461586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis B, C, Treponema pallidum and Toxoplasma gondii co-infections in HIV infected patients].
    Pérez C C; Cerón A I; Fuentes L G; Zañartu S C; Balcells M ME; Ajenjo H C; Rabagliati B R; Labarca L J; Acuña L G
    Rev Med Chil; 2009 May; 137(5):641-8. PubMed ID: 19701553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C and human immunodeficiency virus infection.
    Thomas DL
    Hepatology; 2002 Nov; 36(5 Suppl 1):S201-9. PubMed ID: 12407595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era.
    Madeddu G; Porqueddu EM; Cambosu F; Saba F; Fois AG; Pirina P; Mura MS
    Infection; 2008 Jun; 36(3):231-6. PubMed ID: 18463787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in bacteremia in the pre- and post-highly active antiretroviral therapy era among HIV-infected children in the US Perinatal AIDS Collaborative Transmission Study (1986-2004).
    Kapogiannis BG; Soe MM; Nesheim SR; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2008 May; 121(5):e1229-39. PubMed ID: 18450865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.